Jefferies downgraded NPS Pharmaceuticals Inc. (NASDAQ: NPSP) from Buy to Hold with a price target of $38 on valuation.

This article: 117 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE